Reproductive Endocrinology and Infertility Treatment Options
Couples and individuals who seek to start a family but may face challenges in terms of achieving pregnancy now have multiple fertility options. Our team of fertility doctors and medical professionals utilize advanced technology and the latest reproductive medicine treatments to help couples and individuals build their own families.
First, meeting with a board-certified reproductive endocrinologist will put you on the right path to fully understanding your options for how you can achieve your goal of having a child. During this initial step, your reproductive endocrinologist will ask you questions regarding your medical history. After the consultation, you are likely to have a physical examination and transvaginal ultrasound. Once your initial appointment is complete, you will most likely undergo a range of diagnostic tests to confirm the details about the long-term reproductive health of you and, if necessary, your partner.
There are numerous fertility treatment options ranging from basic approaches, including ovulation induction with intrauterine insemination (IUI), to more complex infertility treatment, such as in vitro fertilization (IVF) with preimplantation genetic testing (PGT) and comprehensive chromosomal screening (CCS) of embryos. RMA of New York doctors will recommend an individualized treatment plan intended to provide you with the highest chances of conceiving a healthy child.
We may need to perform additional diagnostic tests if male or female infertility risk factors exist, if the female is over the age of 35, and also if the couple is curious about the male's fertility potential.
Female Infertility Treatments
There are many ways we handle improving the likelihood for a woman to become pregnant. It is, however, important to understand the causes of infertility first.
There are a wide range of causes related to female infertility. An inability to ovulate can be caused by a hormone imbalance, thyroid problems, or polycystic ovaries. Furthermore, an inability to become pregnant might also stem from damage to the fallopian tubes or uterus due to pelvic infections or inflammatory disease, or from conditions including fibroids, polyps, male factor, or endometriosis.
Some additional procedures to treat female infertility include:
- Surgery for fibroids, polyps, endometriosis, and other issues
- Blastocyst culture and transfer
- Preimplantation Genetic Testing (PGT)
- Comprehensive chromosome screening (CCS)
- Embryo cryopreservation
- Egg donation
- Fertility preservation through egg freezing (oocyte cryopreservation)
- Third party reproduction, including specialized care for LGBT individuals, couples, and single parents to be
- Minimally invasive surgery
Fertility preservation is a safe and effective method for many women of reproductive age to safely store their eggs (oocytes) and delay child-bearing efforts for numerous reasons. RMA of New York offers oocyte cryopreservation, which gives women the option to choose when to pursue pregnancy by freezing or vitrifying their retrieved eggs and later rewarming and transferring the fertilized eggs into the uterus when the woman is ready for pregnancy.
Egg freezing is commonly used for fertility preservation in women with cancer prior to receiving chemotherapy (oncofertility treatment) and in women who are single and not yet ready to conceive.
RMA of New York performs a process of egg freezing known as vitrification, which allows for the ”ultra-rapid-freezing” of oocytes. This process eliminates the possibility of hazardous ice crystals to form around the egg during thawing. Watch a video of the egg vitrification process performed at RMA of New York.
RMA of New York offers free seminars to learn more about egg freezing. Register for an upcoming informational event, or call 212-756-5777 for more information.
Male Infertility Treatments
Although inability to reproduce is often associated with women, studies have shown that men make up approximately 40 percent of all infertility cases.
There are multiple causes for male infertility relating to abnormal sperm or a lack of sperm (azoospermia), germ-cell aplasia, low semen production, low sperm count, low sperm motility, and varicocele, in addition to being caused by birth defects or prior health illnesses.
Although the number of causes related to male infertility may seem daunting, doctors at RMA of New York have the ability to complete an array of comprehensive tests that will determine the reproductive health of the male partner and ways to treat the causes of male infertility.
To best understand the underlying cause of male infertility, we may ask men to undergo a history and physical examination, as well as semen analyses and blood tests.
Additional services include andrology testing, as well as the most modern reproductive technologies available to reproductive medicine, including:
- Medical and Hormonal Remedies
- Varicocele Repair
- Microsurgical Reconstruction
- Vasectomy Reversal
- Assisted Reproductive Technology – IntraCytoplasmic Sperm Injection (ART – ICSI)
- Testicular Sperm Retrieval
Doctors and researchers at RMA of New York place an emphasis on determining the causes of infertility and are learning every day about genetic indicators in the female body to predict their ability to reproduce. We commit ourselves to helping couples and individuals with the opportunity to build families through the best possible options available in fertility treatment.
Other studies that our doctors and researchers are currently engaging in deal with screening embryos for potential diseases and successful implantation potential, gaining a deeper understanding of Polycystic Ovarian Syndrome on pregnancies, epigenetics and cellular programming, as well as the use of stem cell transplantation. Our team has published their findings on ectopic pregnancies and same-sex female parenting. New forms of technology at Mount Sinai's IVF program include time lapse photography to understand embryonic cell division and viability as well as the use of cryogenics in fertility preservation for healthy women and women with cancer (oncofertility).
Learn more about our continued research, or participate in one of our current clinical studies.